T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells

201184 citationsletter

Authors

Good health and well-being

Published in: Leukemia

Volume 26, Issue 2, pp. 365-367

Field-Weighted Citation Impact: 1.68